BAAM
BSX icon

Baker Avenue Asset Management’s Boston Scientific BSX Stock Holding History

Baker Avenue Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
7,703
-965
-11% -$52.4K 0.01% 655
2026
Q1 		$544K Sell
8,668
-19,153
-69% -$1.53M 0.01% 402
2025
Q4 		$2.65M Buy
27,821
+1,190
+4% +$117K 0.06% 188
2025
Q3 		$2.6M Buy
26,631
+543
+2% +$56.2K 0.06% 189
2025
Q2 		$2.8M Sell
26,088
-1,410
-5% -$143K 0.08% 166
2025
Q1 		$2.77M Buy
+27,498
New +$2.77M 0.09% 171
2023
Q4 		– Sell
-167
Closed -$8.82K – 525
2023
Q3 		$8.82K Sell
167
-53
-24% -$2.78K ﹤0.01% 790
2023
Q2 		$11.9K Buy
220
+14
+7% +$731 ﹤0.01% 716
2023
Q1 		$10.3K Sell
206
-29
-12% -$1.37K ﹤0.01% 760
2022
Q4 		$10.9K Buy
+235
New +$10.2K ﹤0.01% 694
2019
Q3 		– Sell
-5,593
Closed -$240K – 240
2019
Q2 		$240K Buy
+5,593
New +$215K 0.02% 221
2017
Q2 		– Sell
-24,268
Closed -$604K – 202
2017
Q1 		$604K Buy
24,268
+1,823
+8% +$44.3K 0.08% 131
2016
Q4 		$485K Buy
22,445
+2,220
+11% +$48.4K 0.07% 149
2016
Q3 		$481K Buy
20,225
+655
+3% +$15.6K 0.07% 141
2016
Q2 		$457K Sell
19,570
-390
-2% -$8.44K 0.07% 136
2016
Q1 		$375K Sell
19,960
-3,640
-15% -$63.9K 0.06% 142
2015
Q4 		$435K Buy
+23,600
New +$423K 0.06% 128

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baker Avenue Asset Management's BSX Position: Q2 2026 in Review

Baker Avenue Asset Management reduced its Boston Scientific (BSX) stake by 11% in Q2 2026, selling an estimated $52.4K and leaving 7,703 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #655.

Baker Avenue Asset Management first reported a position in BSX in Q4 2015 and has held it in 17 quarters since. The position peaked at $2.8M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Baker Avenue Asset Management held 7,703 shares of Boston Scientific worth $329K as of Q2 2026.
  • Baker Avenue Asset Management sold 965 Boston Scientific shares in Q2 2026, an estimated $52.4K.
  • Boston Scientific made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #655 holding.
  • Baker Avenue Asset Management first reported a position in Boston Scientific in Q4 2015 and has held it in 17 quarters since.
  • Baker Avenue Asset Management's Boston Scientific position peaked at $2.8M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.